Abstract:Inflammatory bowel disease (IBD) increases the risk of colorectal cancer, and it has the potential to diminish the quality of life. Clinical and experimental evidence demonstrate protective aspects of parasitic helminth infection against IBD. However, studies on the inhibition of inflammation by helminth infection have overlooked a key determinant of health: the gut microbiota. Although infection with helminths induces alterations in the host microbiota composition, the potential influence and mechanism of helminth infections induced changes in the gut microbiota on the development of IBD has not yet been elucidated. In this study, we analyzed the intersection of helminth Trichinella spiralis and gut bacteria in the regulation of colitis and related mechanisms. T . spiralis infected mice were treated with antibiotics or cohoused with wild type mice, then challenged with dextran sodium sulfate (DSS)-colitis and disease severity, immune responses and goblet cells assessed. Gut bacteria composition was assessed by 16S rRNA sequencing and short-chain fatty acids (SCFAs) were measured. We found that protection against disease by infection with T . spiralis was abrogated by antibiotic treatment, and cohousing with T . spiralis - infected mice suppressed DSS-colitis in wild type mice. Bacterial community profiling revealed an increase in the abundance of the bacterial genus Muribaculum and unclassified_Muribaculaceae in mice with T . spiralis infection or mice cohoused with T . spiralis - infected mice. Metabolomic analysis demonstrated significantly increased propionic acid in feces from T . spiralis - infected mice. Data also showed that the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels in mice. These findings identify the gut microbiome as a critical component of the anti- colitic effect of T . spiralis and gives beneficial insights into the processes by which helminth alleviates colitis. IBD encompasses Crohn's Disease and Ulcerative Colitis. It affects both children and adults. Reports have highlighted the potential use of helminths or their byproducts as a possible treatment for IBD. Accumulating evidence also suggests that the gut microbiota is a key factor in modulating IBD. In this study, we revealed the protective effect of a prior infection with T . spiralis on DSS- induced colitis in mice. Specifically, T . spiralis infection reshaped the gut microbiome of mice, resulting in an increased abundance of SCFA-producing bacteria Muribaculum and unclassified_Muribaculaceae and thereby producing a larger amount of propionic acid. Furthermore, the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels, ultimately ameliorating experimental colitis. These findings suggest that the modulation of host microbiota during T . spiralis infection plays a crucial role in the suppression of colitis, and any intention-to-treat with helminth therapy should be based on the patient's immunological and microbiological response to the helminth.

The Protective Effect of the Recombinant 53-kDa Protein of Trichinella spiralis on Experimental Colitis in Mice

Trichinella- derived protein ameliorates colitis by altering the gut microbiome and improving intestinal barrier function

Immune Protection of a Helminth Protein in the DSS-Induced Colitis Model in Mice

Effect of Recombinant Serine Protease from Adult Stage of Trichinella Spiralis on TNBS-induced Experimental Colitis in Mice.

The Protective Effect of Trichinella Spiralis Recombinant T668 Protein on Mice Colitis

Trichinella spiralis Paramyosin Induces Colonic Regulatory T Cells to Mitigate Inflammatory Bowel Disease

Effect of recombinant serine protease from newborn larval stage of Trichinella spiralis on 2,4,6-trinitrobenzene sulfonic acid-induced experimental colitis in mice

Effect of recombinant serine protease from newborn larval stage of <i>Trichinella spiralis</i> on 2,4,6-trinitrobenzene sulfonic acid-induced experimental colitis in mice

Trichinella Spiralis Infection Protects Mice from TNBS-induced Colitis

Exposure Time Determines the Protective Effect of Trichinella Spiralis on Experimental Colitis.

The gut microbiota is essential for Trichinella spiralis —Evoked suppression of colitis

Excretory/secretory Products from Trichinella Spiralis Adult Worms Ameliorate DSS-induced Colitis in Mice.

Extracellular Vesicles Derived From Trichinella spiralis Muscle Larvae Ameliorate TNBS-Induced Colitis in Mice

Interactions between Trichinella spiralis infection and induced colitis in mice

Extracellular Vesicles Derived From<i>Trichinella spiralis</i>Muscle Larvae Ameliorate TNBS-Induced Colitis in Mice

Extracellular vesicles derived from Trichinella spiralis prevent colitis by inhibiting M1 macrophage polarization

The protective effect of oral colitis-derived proteins in a murine model of inflammatory bowel disease is associated with an increase in γδ T cells in large intestinal mucosa

The Protective Effect Of Oral Colitis-Derived Proteins In A Murine Model Of Inflammatory Bowel Disease Is Associated With An Increase In Gamma Delta T Cells In Large Intestinal Mucosa

Effects of Trichinella Spiralis on Th1/Th2 Type Cytokine Gene Expresion in Mice with TNBS Colitis

Tryptanthrin Protects Mice against Dextran Sulfate Sodium-Induced Colitis through Inhibition of TNF-α/NF-κB and IL-6/STAT3 Pathways

Therapeutic Potential of Recombinant Cystatin from Schistosoma Japonicum in TNBS-induced Experimental Colitis of Mice.